undamentalytics Newsletter

XTL Biopharmaceuticals LTD valuation and forecast

Explore the models for XTL Biopharmaceuticals LTD, adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Price history

Loading chart…

Third-party market data · may be delayed

XTLB valuation questions

How does Fundamentalytics value XTL Biopharmaceuticals LTD?
We use the models that fit XTL Biopharmaceuticals LTD's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to XTL Biopharmaceuticals LTD.

Compare with peers